Unraveling the mechanism of the anticancer potential of emodin using 2D and spheroid models of A549 cells

• Published in: Biochemical and biophysical research communications 2024-12, Vol.736, p.150908, Article 150908
• Main Authors: Sangseekew, Wannapa, Ornnork, Narittira, Sornprachum, Thiwaree, Sirirak, Jitnapa, Lirdprapamongkol, Kriengsak, Boonsombat, Jutatip, Svasti, Jisnuson, Keeratichamroen, Siriporn
• Format: Article
• Language: English
• Subjects: A549 Cells; Antineoplastic Agents - pharmacology; Apoptosis - drug effects; Cancer therapy; Cell Culture Techniques; Cell Movement - drug effects; Cell Proliferation - drug effects; Emodin; Emodin - pharmacology; FAK; Humans; JAK2; Molecular Docking Simulation; Neoplasm Invasiveness; Spheroid culture; Spheroids, Cellular - drug effects
• ISSN: 0006-291X; 1090-2104; 1090-2104
• DOI: 10.1016/j.bbrc.2024.150908

The increasing global cancer burden necessitates the development of new treatment options. Herbal medicine offers a viable alternative to conventional cancer treatments. Numerous studies have shown that 3-dimensional (3D) cell culture more accurately represents tumor characteristics in vivo. Therefore, this study utilized tumor spheroids to explore the therapeutic efficacy of emodin, a natural product-derived bioactive agent. We investigated differences in chemotherapeutic response between A549 cells cultured in 2D versus spheroids, assessing key factors influencing cancer progression, including apoptosis, cell proliferation, cell cycle, migration and invasion. The findings revealed that spheroid cells displayed increased resistance to emodin compared to cells cultured in 2D. Emodin exhibited a more pronounced cytostatic effect in 2D cells, while its cytotoxic effect was more prominent in spheroid cells. Moreover, emodin treatment diminished the migratory and invasive capabilities of the cells. Mechanistic investigations indicated that emodin triggered apoptosis in A549 cells via the mitochondrial apoptotic pathway. Emodin-treated cells exhibited a significant reduction in the phosphorylation of key cancer progression pathways, including JAK2, STAT3, FAK, and ERK, compared to untreated controls. Molecular docking analysis confirmed the interactions of emodin with JAK2 and FAK. These findings suggest that the JAK2/STAT3 and FAK/ERK signaling pathways may serve as critical drivers of the therapeutic effectiveness of emodin in A549 cells. •Spheroid cells showed higher resistance to emodin's effects than 2D cells.•Emodin displayed more potent cytostatic effects on 2D cells.•Emodin demonstrated stronger cytotoxic effects on spheroid cells.•Emodin induces A549 cell apoptosis through the mitochondrial apoptotic pathway.•The JAK2/STAT3 and FAK/ERK pathways could be critical to emodin's efficacy.